PTGS2 and breast carcinoma: Previous studies have shown significant decreases in various solid tumour growths following the administration of COX-2 inhibitors (Connolly et al, 2002; Howe et al, 2002), although there is still a need to clarify the mechanism of action in breast cancer and identify surrogate markers of effect.